BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
BioTime Presents Updated Data from OpRegen® Phase I/IIa Clinical Study at the Association for Research in Vision and Ophthalmology Annual Meeting
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target=&quo…
PUMA-G System for Placing Gastronomy Feeding Tubes at Point of Care Cleared by FDA
Percutaneous gastrostomy feeding tubes are placed by making a puncture through the abdominal wall and into the stomach. This requires an operating room and all that that entails, including a surgeon, anesthesia, imaging equipment, and associated clinicians. Now a new system, made by CoapTech, a Baltimore, MD firm, has been cleared by the FDA that [ (Read more...)
Aerpio Pharmaceuticals Presents Data Showing Potential of AKB-9778, a VE-PTP Inhibitor/Tie2 Activator, to Lower Intra-ocular Pressure in Human Subjects
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, presented data showing the potential of AKB-97…
Mount Sinai study provides fresh insights into cellular pathways that cause cancer
Mount Sinai researchers have broken new ground in the understanding of the MDM2 gene–which is often overexpressed in cancer–finding that when it acts with a specific protein, it can lead to cancer cell death.
A new strategy for managing diabetic macular edema in people with good vision
A change to the approach for treating diabetic macular edema may be on the way, thanks to a study published today in the Journal of the American Medical Association.